Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04635189
What this trial is testing

Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Rochester 28
Very early researchLooking for participantsNCT05423210
What this trial is testing

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Stony Brook University 12
Testing effectiveness (Phase 2)Looking for participantsNCT07159620
What this trial is testing

Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients

Who this might be right for
Adult T-cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University 27
Early research (Phase 1)Study completedNCT02326584
What this trial is testing

A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaAcute Myelogenous Leukemia
Seagen Inc. 116
Not applicableWithdrawnNCT02590497
What this trial is testing

Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery

Who this might be right for
Glioblastoma
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03897491
What this trial is testing

PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

Who this might be right for
Glioblastoma
photonamic GmbH & Co. KG 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04052880
What this trial is testing

Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM

Who this might be right for
Newly Diagnosed Multiple Myeloma
Larysa Sanchez 17
Testing effectiveness (Phase 2)WithdrawnNCT05664893
What this trial is testing

Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)

Who this might be right for
HER2 Negative Breast Cancer Not Immediately Operated
Centre Antoine Lacassagne
Very early researchStudy completedNCT01165632
What this trial is testing

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+13 more
Mayo Clinic 24
Testing effectiveness (Phase 2)Looking for participantsNCT06630091
What this trial is testing

A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study

Who this might be right for
Peripheral T Cell Lymphoma
M.D. Anderson Cancer Center 30
Not applicableStudy completedNCT00364624
What this trial is testing

Adrenal Function in Patients With Newly Diagnosed Lung Cancer

Who this might be right for
Lung CancerAdrenal Insufficiency
Princess Margaret Hospital, Hong Kong 133
Large-scale testing (Phase 3)Study completedNCT00017147
What this trial is testing

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
SWOG Cancer Research Network 183
Testing effectiveness (Phase 2)Active Not RecruitingNCT02923778
What this trial is testing

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Who this might be right for
LeiomyosarcomaLiposarcomaSarcoma G2+6 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT00471497
What this trial is testing

Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Myelogenous Leukemia, Chronic
Novartis Pharmaceuticals 846
Not applicableWithdrawnNCT03176888
What this trial is testing

Health Benefits of HIT for Breast Cancer Patients

Who this might be right for
Breast Cancer
University of Stirling
Large-scale testing (Phase 3)Study completedNCT00703820
What this trial is testing

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
St. Jude Children's Research Hospital 324
Testing effectiveness (Phase 2)Study completedNCT01481194
What this trial is testing

ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Vejle Hospital 35
Not applicableEnded earlyNCT00891969
What this trial is testing

Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 77
Large-scale testing (Phase 3)UnknownNCT00954174
What this trial is testing

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Mixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube Carcinoma+39 more
GOG Foundation 637
Large-scale testing (Phase 3)Looking for participantsNCT05939180
What this trial is testing

VA vs DA for Newly Diagnosed Hig-risk AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 116
Next Page